Copyright Reports & Markets. All rights reserved.

Global TB Vaccines Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 TB Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key TB Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global TB Vaccines Market Size Growth Rate by Type
    • 1.4.2 Mobile
    • 1.4.3 Benchtop
  • 1.5 Market by Application
    • 1.5.1 Global TB Vaccines Market Size Growth Rate by Application
    • 1.5.2 For Water Analysis
    • 1.5.3 Measuring
    • 1.5.4 Laboratory
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global TB Vaccines Market Size, Estimates and Forecasts
    • 2.1.1 Global TB Vaccines Revenue 2015-2026
    • 2.1.2 Global TB Vaccines Sales 2015-2026
  • 2.2 Global TB Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global TB Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global TB Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global TB Vaccines Competitor Landscape by Players

  • 3.1 TB Vaccines Sales by Manufacturers
    • 3.1.1 TB Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 TB Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 TB Vaccines Revenue by Manufacturers
    • 3.2.1 TB Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 TB Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global TB Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by TB Vaccines Revenue in 2019
    • 3.2.5 Global TB Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 TB Vaccines Price by Manufacturers
  • 3.4 TB Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 TB Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers TB Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into TB Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global TB Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global TB Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global TB Vaccines Revenue by Type (2015-2020)
    • 4.1.3 TB Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global TB Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global TB Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global TB Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 TB Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global TB Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global TB Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global TB Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global TB Vaccines Revenue by Application (2015-2020)
    • 5.1.3 TB Vaccines Price by Application (2015-2020)
  • 5.2 TB Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global TB Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global TB Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global TB Vaccines Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America TB Vaccines by Country
    • 6.1.1 North America TB Vaccines Sales by Country
    • 6.1.2 North America TB Vaccines Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America TB Vaccines Market Facts & Figures by Type
  • 6.3 North America TB Vaccines Market Facts & Figures by Application

7 Europe

  • 7.1 Europe TB Vaccines by Country
    • 7.1.1 Europe TB Vaccines Sales by Country
    • 7.1.2 Europe TB Vaccines Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe TB Vaccines Market Facts & Figures by Type
  • 7.3 Europe TB Vaccines Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific TB Vaccines by Region
    • 8.1.1 Asia Pacific TB Vaccines Sales by Region
    • 8.1.2 Asia Pacific TB Vaccines Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific TB Vaccines Market Facts & Figures by Type
  • 8.3 Asia Pacific TB Vaccines Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America TB Vaccines by Country
    • 9.1.1 Latin America TB Vaccines Sales by Country
    • 9.1.2 Latin America TB Vaccines Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America TB Vaccines Market Facts & Figures by Type
  • 9.3 Central & South America TB Vaccines Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa TB Vaccines by Country
    • 10.1.1 Middle East and Africa TB Vaccines Sales by Country
    • 10.1.2 Middle East and Africa TB Vaccines Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa TB Vaccines Market Facts & Figures by Type
  • 10.3 Middle East and Africa TB Vaccines Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Merck & Co.,Inc
    • 11.1.1 Merck & Co.,Inc Corporation Information
    • 11.1.2 Merck & Co.,Inc Description and Business Overview
    • 11.1.3 Merck & Co.,Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Merck & Co.,Inc TB Vaccines Products Offered
    • 11.1.5 Merck & Co.,Inc Related Developments
  • 11.2 Sanofi Pasteur
    • 11.2.1 Sanofi Pasteur Corporation Information
    • 11.2.2 Sanofi Pasteur Description and Business Overview
    • 11.2.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Sanofi Pasteur TB Vaccines Products Offered
    • 11.2.5 Sanofi Pasteur Related Developments
  • 11.3 Japan BCG Laboratory
    • 11.3.1 Japan BCG Laboratory Corporation Information
    • 11.3.2 Japan BCG Laboratory Description and Business Overview
    • 11.3.3 Japan BCG Laboratory Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Japan BCG Laboratory TB Vaccines Products Offered
    • 11.3.5 Japan BCG Laboratory Related Developments
  • 11.4 China National Biotec Group
    • 11.4.1 China National Biotec Group Corporation Information
    • 11.4.2 China National Biotec Group Description and Business Overview
    • 11.4.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 China National Biotec Group TB Vaccines Products Offered
    • 11.4.5 China National Biotec Group Related Developments
  • 11.5 Serum Institute
    • 11.5.1 Serum Institute Corporation Information
    • 11.5.2 Serum Institute Description and Business Overview
    • 11.5.3 Serum Institute Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Serum Institute TB Vaccines Products Offered
    • 11.5.5 Serum Institute Related Developments
  • 11.6 India Pvt. Ltd
    • 11.6.1 India Pvt. Ltd Corporation Information
    • 11.6.2 India Pvt. Ltd Description and Business Overview
    • 11.6.3 India Pvt. Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 India Pvt. Ltd TB Vaccines Products Offered
    • 11.6.5 India Pvt. Ltd Related Developments
  • 11.7 InterVax Ltd
    • 11.7.1 InterVax Ltd Corporation Information
    • 11.7.2 InterVax Ltd Description and Business Overview
    • 11.7.3 InterVax Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 InterVax Ltd TB Vaccines Products Offered
    • 11.7.5 InterVax Ltd Related Developments
  • 11.8 GreenSignal
    • 11.8.1 GreenSignal Corporation Information
    • 11.8.2 GreenSignal Description and Business Overview
    • 11.8.3 GreenSignal Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 GreenSignal TB Vaccines Products Offered
    • 11.8.5 GreenSignal Related Developments
  • 11.9 Bio Pharma Limited
    • 11.9.1 Bio Pharma Limited Corporation Information
    • 11.9.2 Bio Pharma Limited Description and Business Overview
    • 11.9.3 Bio Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Bio Pharma Limited TB Vaccines Products Offered
    • 11.9.5 Bio Pharma Limited Related Developments
  • 11.10 Statens Serum Institut
    • 11.10.1 Statens Serum Institut Corporation Information
    • 11.10.2 Statens Serum Institut Description and Business Overview
    • 11.10.3 Statens Serum Institut Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Statens Serum Institut TB Vaccines Products Offered
    • 11.10.5 Statens Serum Institut Related Developments
  • 11.1 Merck & Co.,Inc
    • 11.1.1 Merck & Co.,Inc Corporation Information
    • 11.1.2 Merck & Co.,Inc Description and Business Overview
    • 11.1.3 Merck & Co.,Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Merck & Co.,Inc TB Vaccines Products Offered
    • 11.1.5 Merck & Co.,Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 TB Vaccines Market Estimates and Projections by Region
    • 12.1.1 Global TB Vaccines Sales Forecast by Regions 2021-2026
    • 12.1.2 Global TB Vaccines Revenue Forecast by Regions 2021-2026
  • 12.2 North America TB Vaccines Market Size Forecast (2021-2026)
    • 12.2.1 North America: TB Vaccines Sales Forecast (2021-2026)
    • 12.2.2 North America: TB Vaccines Revenue Forecast (2021-2026)
    • 12.2.3 North America: TB Vaccines Market Size Forecast by Country (2021-2026)
  • 12.3 Europe TB Vaccines Market Size Forecast (2021-2026)
    • 12.3.1 Europe: TB Vaccines Sales Forecast (2021-2026)
    • 12.3.2 Europe: TB Vaccines Revenue Forecast (2021-2026)
    • 12.3.3 Europe: TB Vaccines Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific TB Vaccines Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: TB Vaccines Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: TB Vaccines Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: TB Vaccines Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America TB Vaccines Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: TB Vaccines Sales Forecast (2021-2026)
    • 12.5.2 Latin America: TB Vaccines Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: TB Vaccines Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa TB Vaccines Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: TB Vaccines Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: TB Vaccines Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: TB Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key TB Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 TB Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    TB Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global TB Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the TB Vaccines market is segmented into
    Mobile
    Benchtop

    Segment by Application, the TB Vaccines market is segmented into
    For Water Analysis
    Measuring
    Laboratory
    Others

    Regional and Country-level Analysis
    The TB Vaccines market is analysed and market size information is provided by regions (countries).
    The key regions covered in the TB Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and TB Vaccines Market Share Analysis
    TB Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in TB Vaccines business, the date to enter into the TB Vaccines market, TB Vaccines product introduction, recent developments, etc.

    The major vendors covered:
    Merck & Co.,Inc
    Sanofi Pasteur
    Japan BCG Laboratory
    China National Biotec Group
    Serum Institute
    India Pvt. Ltd
    InterVax Ltd
    GreenSignal
    Bio Pharma Limited
    Statens Serum Institut

    Buy now